Table 2 Treatment outcomes of rectal carcinoid tumors
Number | Tumor size | CR-E | CR-P | ARM (mm) | ICR-P | UR-P | CR-C | Follow up period (months) | Recurrence rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
LEMR | 25 (17%) | 6.3 ± 2.7 mm (range, 3–11 mm) | 25 (100%) | 25 (100%) | 1.3 | 0 (0%) | 0 (0%) | 100% (25/25) | 8.6 (6–26) | 0 |
EMR | 31 (21%) | 6.6 ± 2.3 mm (range, 3–12 mm) | 30 (97%) | 13 (42%) | 0.4 | 8 (26%) | 10 (32%) | 71% (22/31) | 12.8 (8–61) | 29 |
Polypectomy | 30 (21%) | 7.4 ± 4.5 mm (range, 2–20 mm) | 18 (60%) | 1 (3%) | 0.5 | 17 (57%) | 12 (40%) | 17% (3/18) | 19.3 (2–47) | 83 |
Biopsy removal | 46 (32%) | 3.4 ± 1.5 mm (range, 1–6 mm) | 2 (4%) | 0.1 | 21 (46%) | 23 (50%) | 7% (2/27) | 21.6 (1–84) | 93 | |
Surgical resection | 13 (9%) | 9.7 ± 7.8 mm (range, 2–25 mm) | 11 (85%) | 1.5 | 0 (0%) | 2 (15%) | 100% (13/13) | 27.0 (9–91) | 0 |